|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | |
| A61K 38/15 | |||
| G01N 33/68 |
| (11) | Patento numeris | 2893350 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13767166.5 |
| Europos patento paraiškos padavimo data | 2013-09-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-07-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/058379 |
| Data | 2013-09-06 |
| (87) | Numeris | WO 2014/039744 |
| Data | 2014-03-13 |
| (30) | Numeris | Data | Šalis |
| 201261698341 P | 2012-09-07 | US | |
| 201261726464 P | 2012-11-14 | US | |
| 201361784501 P | 2013-03-14 | US |
| (72) |
TROWE, Torsten, Bernhard, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | RESISTANCE BIOMARKERS FOR HDAC INHIBITORS |
| RESISTANCE BIOMARKERS FOR HDAC INHIBITORS |